INHALATIONAL ANESTHETICS WITH THEIR PHARMACOKINETIC PROPERTIES

Ингаляционные анестетики и их фармакокинетические свойства
Ljubica Mikjunovikj-Derebanova
2025-05-28

blood solubilitycytochrome P450 metabolisminhalational anestheticsminimum alveolar concentrationpharmacokinetics
Inhalational anesthetics are the most common drugs used for providing general anesthesia for surgery. They are used to induce unconsciousness, amnesia and immobility. In search for ideal anesthetic gas there have been discovered many agents, but sadly the perfect inhalational drug has not been produced. The pharmacokinetics of inhalational anesthetics depends on their physical properties. The rate of uptake and elimination of the inhalational anesthetics from the alveoli in mainly depends on their blood solubility. The main driving force of absorption and distribution of the gas through the body is partial pressure gradient on both sides of each barrier in the gas flow, and the therapeutic effect of the gas depends of the partial pressure of the anesthetic in the brain. All inhalational anesthetics, with exception of nitrous oxide and xenon, are metabolized (in different degrees) in liver via cytochrome P450 enzymes. The potency of different inhalational anesthetics is expressed via minimum alveolar concentration, which is defined as concentration of the anesthetics that prevent movement in 50% of the patients in response to surgical incision under standard conditions. Nitrous oxide and volatile halogenated ethers (desflurane, isoflurane, sevoflurane) are examples of medical gases that are greenhouse gases with great impact to global warming. This article summarizes a brief historical timeline of the inhalational anesthetics, mechanisms of action, physical characteristics and pharmacokinetic properties of inhalational agents with a short overview of their toxicity and pollution of the environment.
1
Absorption and distribution are driven by partial-pressure gradients across gas-exchange barriers, while anesthetic effect depends on the agent’s partial pressure in the brain.
2
Anesthetic potency is quantified by minimum alveolar concentration, while nitrous oxide and volatile halogenated ethers contribute substantially to greenhouse-gas emissions.
3
Except for nitrous oxide and xenon, inhalational anesthetics undergo hepatic metabolism through cytochrome P450 enzymes to varying degrees.
4
No perfect inhalational anesthetic has yet been developed, despite the discovery of multiple agents for producing unconsciousness, amnesia, and immobility.
5
The pharmacokinetics of inhalational anesthetics is governed by physical properties, particularly blood solubility, which determines alveolar uptake and elimination rates.

inhalational anesthetic agents used for general anesthesia

their pharmacokinetic properties, including alveolar uptake and elimination, distribution driven by partial-pressure gradients, metabolism, and potency

Publication Details
Publication Date
2025-05-28
Journal
Publisher
ISSN
Cited by
0
Access Type
Author Information
Authors
Ljubica Mikjunovikj-Derebanova
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%